---  
layout: startup_page  
title: "NextPoint Therapeutics"  
id: "nextpointtx.com"  
permalink: "/nextpointtherapeuticsnextpointtx.com02142024/"  
website: "https://nextpointtx.com/"  
funding_round: "Series B"  
funding_amount: "$122.5M"  
investors: "Catalio Capital Management, MPM BioImpact, Leaps by Bayer, Sanofi Ventures, Invus, Sixty Degree Capital, Dana-Farber Cancer Instituteâ€™s Binney Street Capital, Gordon Freeman, Arkin Bio-Capital, WTT investment Ltd"  
about: "NextPoint Therapeutics is a clinical-stage biotechnology company developing precision oncology therapeutics targeting the HHLA2 pathway. Their innovative approach integrates foundational science with a defined clinical biomarker strategy to deliver a new class of monotherapies. The company is advancing multiple assets into clinical trials to exploit HHLA2's role in both immune checkpoint and tumor-targeting."  
markets: "Biotechnology, Oncology, Immuno-oncology, Health Care, Life Science, Therapeutics"  
hq: "Cambridge, Massachusetts, United States"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/nextpoint-therapeutics"  
twitter: "https://twitter.com/NextPointTX"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/nextpoint-therapeutics"  
pitchbook: ""  

date_display: "14-Feb-2024"  
date: "2024-02-14"

# SEO Optimization  
meta_title: "NextPoint Therapeutics - Series B Funding ($122.5M)"  
meta_description: "NextPoint Therapeutics, NextPoint Therapeutics is a clinical-stage biotechnology company developing precision oncology therapeutics targeting the HHLA2 pathway. Their innovat..."  
meta_keywords: "NextPoint Therapeutics, Biotechnology, Oncology, Immuno-oncology, Health Care, Life Science, Therapeutics, Series B funding"  
canonical_url: "https://startup.projectstartups.com/nextpointtherapeuticsnextpointtx.com02142024/"  
---